“…Regardless of the origins of autoreactive cells, they must be stimulated to divide and differentiate in order to generate Murakami et al, 1992;Nemazee and Burki, 1989;Wang and Shlomchik, 1998 Receptor editing anti-MHCII Tg, 3H9/Vk4 anti-dsDNA Tg, 3H9 or 56R site-directed Tg, HEL site-directed Tg with mHEL cells express an endogenous V L rather than the Tg-encoded one, or cells express a limited repertoire of L chains that veto autoreactivity Gay et al, 1993;Hippen et al, 2005;Li et al, 2001;Tiegs et al, 1993 Allelic inclusion anti-MHC II site-directed Tg, 3H9 56R cells coexpress an endogenous V L with the Tg-encoded one, or cells express two L chains, including one that vetoes autoreactivity Li et al, 2002b;Liu et al, 2005 Anergy anti-HEL Tg with sHEL, anti-DNA (3H9/Vl 1 ), anti-Sm Tg (2-12), ArsA1 cells have variably reduced sIgM expression, shortened life span, and localize to the T-B interface; variably impaired response to LPS and reduced response to BCR ligation Erikson et al, 1991;Goodnow et al, 1988;Merrell et al, 2006;Santulli-Marotto et al, 1998 Clonal ignorance anti-IgG (RF) AM14 Tg, anti-La cells assume a normal follicular B cell phenotype Aplin et al, 2003;Hannum et al, 1996;Shlomchik et al, 1993 autoantibodies. Clues to the nature of this process derive from autoantibody-secreting clones recovered from diseased mice and humans.…”